Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Hypertensive Patients Who did not Respond Fully to Amlodipine Monotherapy: An 8-Week, Randomized, Double-Blind Study

被引:0
|
作者
Pfeiffer, Dietrich [1 ]
Rennie, Nicola [2 ]
Papst, Cheraz Cherif [2 ]
Zhang, Jack [3 ]
机构
[1] Univ Leipzig, Dept Cardiol & Angiol, Leipzig, Germany
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Pharmaceut, E Hanover, NJ USA
关键词
Aliskiren Amlodipine hypertension;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:E119 / E120
页数:2
相关论文
共 50 条
  • [41] d Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone
    Blumenstein, Matthias
    Romaszko, Jerzy
    Calderon, Alberto
    Andersen, Karl
    Ibram, Ghionul
    Liu, Zhaohui
    Zhang, Jack
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 903 - 910
  • [42] Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study
    Cheung, Deanna G.
    Aizenberg, Diego
    Gorbunov, Vladimir
    Hafeez, Kudsia
    Chen, Chien-Wei
    Zhang, Jack
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01): : 150 - 158
  • [43] COMPARISON OF AMLODIPINE AND BENAZEPRIL MONOTHERAPY TO AMLODIPINE PLUS BENAZEPRIL IN PATIENTS WITH SYSTEMIC HYPERTENSION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY
    FRISHMAN, WH
    RAM, CVS
    MCMAHON, FG
    CHRYSANT, SG
    GRAFF, A
    KUPIEC, JW
    HSU, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (11): : 1060 - 1066
  • [44] Safety and Efficacy of Esreboxetine in Patients With Fibromyalgia: An 8-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Arnold, Lesley M.
    Chatamra, Krai
    Hirsch, Ian
    Stoker, Malcolm
    CLINICAL THERAPEUTICS, 2010, 32 (09) : 1618 - 1632
  • [45] An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in Chinese patients with mild to moderate hypertension
    Ueng, Kwo-Chang
    Lin, Lung-Chun
    Voon, Wen-Chol
    Lin, Ming-Cheng
    Liu, Yen-Bin
    Su, Ho-Ming
    Chang, Po-Yuan
    Lin, Tsung-Hsien
    Chen, Wei-Liang
    Wu, Chau-Chung
    Lai, Wen-Ter
    Lin, Chung-Sheng
    BLOOD PRESSURE, 2008, 17 : 24 - 31
  • [46] An eight-week, multi-center, randomized, double-blind, parallel group study comparing the efficacy and safety of amlodipine/valsartan combination therapy versus amlodipine monotherapy in the treatment of stage 2 hypertension
    Destro, M.
    Satlin, L.
    Kandra, A.
    Brunel, P.
    CIRCULATION, 2008, 118 (12) : E183 - E183
  • [47] Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Evaluation Study
    Villa, Giuseppe
    Le Breton, Stephanie
    Ibram, Ghionul
    Keefe, Deborah L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (12): : 1901 - 1911
  • [48] Clinical Efficacy, Safety, and Tolerability of Single-Pill Combination of Dapagliflozin and Linagliptin in Uncontrolled Indian Type 2 Diabetes Mellitus Patients-A Randomized Double-Blind Study
    Ahmad, Jamal
    Ghosh, Sayan
    Kumthekar, Prashant P.
    Upadhyay, Mihir R.
    Sonawane, Kunal S.
    Khalse, Maneesha
    Patel, Kamlesh
    DIABETES, 2024, 73
  • [49] Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension
    Sharma, Akhilesh
    Bagchi, Ananda
    Kinagi, Satish B.
    Sharma, Yogesh Kumar
    Baliga, Vidyagauri P.
    Bollmall, Chandrashekhar
    CLINICAL THERAPEUTICS, 2007, 29 (12) : 2667 - 2676
  • [50] Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial (vol 28, pg 537, 2006)
    Hong, Soon Jun
    Ahn, Tae-Hoon
    Baek, Sang-Hong
    Cho, Wook-Hyun
    Jeon, Hui-Kyung
    Kwan, Jun
    Yoon, Myeong Ho
    Lee, Kwan Jeh
    Lim, Do-Sun
    CLINICAL THERAPEUTICS, 2006, 28 (08) : 1245 - 1245